PD-L1
Interviews and expert commentary tagged “PD-L1” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
PD-L1 Checkpoint Inhibitor Immunotherapy Boosts Survival in Lung Cancer
The Audio Journal of Oncology Reporting from the 2016 Congress of the European Society of Medical Oncology COPENHAGEN—The anti-PD-L1 (programmed cell death ligand-1) immunotherapy agent atezolizumab e
6 December 2016
10:30 secs